Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sevoflurane for painful complex skin ulcers
2022-002321-10Phase 2Active
- Sponsor
- Hospital Universitari d'Igualada
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cutaneous ulcer comparing Topical sevoflurane with Placebo (2 arms). Primary endpoint: Pain reduction during ulcer healing procedure. Started Aug 2022; status: active.
02
Drugs
sevoflurane
03
Conditions
Cutaneous ulcer
Beyond the preview
Go deeper on 2022-002321-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002321-10.